Trials / Completed
CompletedNCT03453281
Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection
Central Macular Thickness, Macular Electroretinogram, and Visual Acuity in Patients With Diabetic Macular Edema After Intravitreal Aflibercept Injection. A One Month Pre-Post Intervention Follow Up Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Indonesia University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a one month pre post intervention study. Subjects with diabetic macular edema were given intravitreal anti VEGF (Aflibercept) injection. Central retinal thickness, macular electrophysiology, and visual acuity were observed one week and one month after injection was given to the eye to describe early anatomical, physiological, and clinical changes. We hypothesized that changes to these outcomes can be found and documented.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aflibercept Injection [Eylea] | Intravitreal Aflibercept injections were performed by vitreoretinal consultant at the place of study. |
Timeline
- Start date
- 2017-10-10
- Primary completion
- 2018-04-09
- Completion
- 2018-05-18
- First posted
- 2018-03-05
- Last updated
- 2018-07-12
Locations
1 site across 1 country: Indonesia
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03453281. Inclusion in this directory is not an endorsement.